1989Behavioural PharmacologyRequires access

Drug treatment of anxiety

M Lader

Open publisher page 6 citations

Abstract

Benzodiazepines are currently the drugs of choice in the treatment of anxiety, and a specific response to benzodiazepines is the central feature of animal models of anxiety. However, the benzodiazepines, in addition to their anxiolytic properties, have a wide range of non-specific cerebral depressant effects. Conversely, numerous non-benzodiazepines have been used to relieve anxiety, and antidepressants are at least as effective as benzodiazepines in some anxiety states. Buspirone and certain other 5-HT receptor ligands also appear to be clinically active, but are relatively inactive in some of the animal models validated by their response to benzodiazepines.

About this research paper

What this paper is about

Benzodiazepines are currently the drugs of choice in the treatment of anxiety, and a specific response to benzodiazepines is the central feature of animal models of anxiety. However, the benzodiazepines, in addition to their anxiolytic properties, have a wide range of non-specific cerebral depressant effects. Conversely, numerous non-benzodiazepines have been used to relieve anxiety, and antidepressants are at least as effective as benzodiazepines in some anxiety states. Buspirone and certain other 5-HT receptor ligands also appear to be clinically active, but are relatively inactive in some of the animal models validated by their response to benzodiazepines.

Why it matters

OpenAlex reports 6 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Benzodiazepines are currently the drugs of choice in the treatment of anxiety, and a specific response to benzodiazepines is the central feature of animal models of anxiety. However, the benzodiazepines, in addition to their anxiolytic properties, have a wide range of non-specific cerebral depressant effects. Conversely, numerous non-benzodiazepines have been used to relieve anxiety, and antidepressants are at least as effective as benzodiazepines in some anxiety states. Buspirone and certain other 5-HT receptor ligands also appear to be clinically active, but are relatively inactive in some of the animal models validated by their response to benzodiazepines.

Key concepts: Buspirone, Anxiolytic, Anxiety, Drug, Anti-Anxiety Agents, Pharmacology, Medicine, Benzodiazepine

Related papers

Back to paper searchBrowse research topicsOriginal source
Drug treatment of anxiety — Research Paper | ScholarLens